{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-001078","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-08-17T12:10:44+00:00","discovered_at":"2026-08-17T12:15:05.295935+00:00","generated_at":"2026-08-17T12:15:20.202988+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Anavex mails stockholder letter backing six director nominees for Sept 24 annual meeting","bullets":["Annual Meeting set for September 24, 2026; record date July 31, 2026; WHITE proxy card urged FOR all six nominees.","Two new independent candidates: Gautam Patel (capital allocation/financial advisory) and Dr. Adrian Senderowicz (drug development/regulatory).","Other nominees: Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Dr. Claus van der Velden.","Company launched www.voteanavex.com with voting instructions; Innisfree M&A serving as proxy solicitor."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-001078","json":"https://secwatch.observer/filing/0001731122-26-001078.json","markdown":"https://secwatch.observer/filing/0001731122-26-001078.md","text":"https://secwatch.observer/filing/0001731122-26-001078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001078/0001731122-26-001078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001078/e7862_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T12:15:20.202988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}